Literature DB >> 18552701

A new Modified Intracerebral Hemorrhage score for treatment decisions in basal ganglia hemorrhage--a randomized trial.

Der-Yang Cho1, Chun-Chung Chen, Wen-Yuan Lee, Han-Chung Lee, Li-Hwei Ho.   

Abstract

OBJECTIVES: To develop a Modified Intracerebral Hemorrhage (MICH) score to determine optimal cut-offs for conservative treatment vs surgical intervention for basal ganglia hemorrhage and to predict outcomes.
DESIGN: Prospective randomized trial.
SETTING: A 1,720-bed medical center affiliated with a university. PATIENTS: In all, 226 patients with basal ganglia hemorrhage who presented at our hospital from 2001-2005.
INTERVENTIONS: Group A (n = 113) underwent endoscopic surgery; group B (n = 113) underwent conservative treatment. Score differences on the Glasgow Outcome Scale and 1-yr Barthel Index were analyzed by chi-square test and Student's t-tests. Cut-offs for MICH scoring were evaluated using receiver operating characteristic curves for calculating the Youden Index. The treatment odds ratio was analyzed by univariate, multivariate, and multiple logistic regressions.
MEASUREMENTS AND MAIN RESULTS: The optimal cut-off point for mortality was a MICH score > or = 3 in which the Youden Index is 0.66 (sensitivity, 76.3%; specificity, 89.8%; area under the receiver operating characteristic curve, 0.897). The positive and negative predictive values were 81.8% and 86.3%, respectively. The treatment odds ratio for surgical treatment was 6.87 (95% confidence interval, 3.13-14.5) at MICH scores > or = 3. The best cut-off for good functional outcomes (Glasgow Outcome Scale > or = 4 or Barthel index > or = 55) was MICH > or = 2. Conservative treatment achieved a better mean Barthel Index at MICH = 0 or 1 than surgical treatment, p < .01. At MICH scores = 3 or 4, 6-month mortality for conservative treatment was higher than for surgical treatment, p < .01 and p = .04, respectively. At MICH scores of 5, all patients died.
CONCLUSIONS: MICH scoring provides a simple, reliable system for treatment decisions regarding basal ganglia hemorrhage and may accurately predict functional outcomes. Conservative treatment is recommended for basal ganglia ICH patients with low MICH scores (0, 1) to preserve neurologic function. Surgery is recommended for patients with a midlevel MICH score to obtain better functional outcomes (MICH = 2) and to reduce mortality (MICH = 3 or 4). At MICH scores = 5, there are no indications for surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18552701     DOI: 10.1097/CCM.0b013e318173fc99

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

1.  Aspirin use or reduced platelet activity predicts craniotomy after intracerebral hemorrhage.

Authors:  Andrew M Naidech; Neil F Rosenberg; Richard A Bernstein; H Hunt Batjer
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 2.  Scoping Review and Commentary on Prognostication for Patients with Intracerebral Hemorrhage with Advances in Surgical Techniques.

Authors:  Stephanie Zyck; Lydia Du; Grahame Gould; Julius Gene Latorre; Timothy Beutler; Alexa Bodman; Satish Krishnamurthy
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

3.  The max-intracerebral hemorrhage score predicts long-term outcome of intracerebral hemorrhage.

Authors:  Yue Suo; Wei-Qi Chen; Yue-Song Pan; Yu-Jing Peng; Hong-Yi Yan; Xing-Quan Zhao; Li-Ping Liu; Yi-Long Wang; Gai-Fen Liu; Yong-Jun Wang
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

4.  Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.

Authors:  Ting-Ting Liu; Xi-Sheng Liu; Meng Zhang; Xue-Ni Liu; Fu-Xiang Zhu; Fang-Ming Zhu; Si-Wen Ouyang; Shan-Bao Li; Chen-Long Song; Hui-Min Sun; Su Lu; Yu Zhang; Jun Lin; Hua-Mei Tang; Zhi-Hai Peng
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-20       Impact factor: 4.553

Review 5.  Clinical grading scales in intracerebral hemorrhage.

Authors:  Brian Y Hwang; Geoffrey Appelboom; Christopher P Kellner; Amanda M Carpenter; Michael A Kellner; Paul R Gigante; E Sander Connolly
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

6.  Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes.

Authors:  David Y Hwang; Cameron A Dell; Mary J Sparks; Tiffany D Watson; Carl D Langefeld; Mary E Comeau; Jonathan Rosand; Thomas W K Battey; Sebastian Koch; Mario L Perez; Michael L James; Jessica McFarlin; Jennifer L Osborne; Daniel Woo; Steven J Kittner; Kevin N Sheth
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

7.  A Delayed Modified ICH Score Outperforms Baseline Scoring in Acute Intracerebral Hemorrhage.

Authors:  Ronda Lun; Vignan Yogendrakumar; Dylan Blacquiere; Michel Shamy; Grant Stotts; Dar Dowlatshahi
Journal:  Neurohospitalist       Date:  2019-12-30

8.  Validation of clinical prediction scores in patients with primary intracerebral hemorrhage.

Authors:  John S Garrett; Mehrzad Zarghouni; Kennith F Layton; Dion Graybeal; Yahya A Daoud
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

9.  Prospective validation of the ICH Score for 12-month functional outcome.

Authors:  J Claude Hemphill; Mary Farrant; Terry A Neill
Journal:  Neurology       Date:  2009-09-02       Impact factor: 9.910

10.  The PLAN score can predict poor outcomes of intracerebral hemorrhage.

Authors:  Wanliang Du; Xingquan Zhao; Yilong Wang; Guitao Zhang; Jiming Fang; Yuesong Pan; Liping Liu; Kehui Dong; Gaifen Liu; Yongjun Wang
Journal:  Ann Transl Med       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.